Harbor Capital Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

Harbor Capital Advisors’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13K	Buy	265 +43	+19%	+$2.21K	﹤0.01%	947
2026 Q1	$13K	Buy	222 +3	+1%	+$195	﹤0.01%	921
2025 Q4	$14K	Sell	219 -4	-2%	-$245	﹤0.01%	868
2025 Q3	$14K	Buy	223 +82	+58%	+$5.71K	﹤0.01%	871
2025 Q2	$11K	Buy	141 +12	+9%	+$1K	﹤0.01%	948
2025 Q1	$11K	Sell	129 -48	-27%	-$3.94K	﹤0.01%	929
2024 Q4	$14K	Buy	177 +33	+23%	+$2.56K	﹤0.01%	880
2024 Q3	$10K	Buy	+144	New	+$10.2K	﹤0.01%	984

Other funds holding PBH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harbor Capital Advisors's PBH Position: Q2 2026 in Review

Harbor Capital Advisors increased its Prestige Consumer Healthcare (PBH) stake by 19% in Q2 2026, buying an estimated $2.21K and bringing the position to 265 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #947.

Harbor Capital Advisors first reported a position in PBH in Q3 2024 and has held it in 8 quarters since. The position peaked at $14K in Q4 2025. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

Harbor Capital Advisors held 265 shares of Prestige Consumer Healthcare worth $13K as of Q2 2026.
Harbor Capital Advisors bought 43 Prestige Consumer Healthcare shares in Q2 2026, an estimated $2.21K.
Prestige Consumer Healthcare made up ﹤0.01% of Harbor Capital Advisors's portfolio in Q2 2026, its #947 holding.
Harbor Capital Advisors first reported a position in Prestige Consumer Healthcare in Q3 2024 and has held it in 8 quarters since.
Harbor Capital Advisors's Prestige Consumer Healthcare position peaked at $14K in Q4 2025.
319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Harbor Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.